Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis.

Brenne AT, Fagerli UM, Shaughnessy JD Jr, Våtsveen TK, Rø TB, Hella H, Zhan F, Barlogie B, Sundan A, Børset M, Waage A.

Eur J Haematol. 2009 May;82(5):354-63. doi: 10.1111/j.1600-0609.2009.01225.x.

2.

IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells.

Lee JW, Chung HY, Ehrlich LA, Jelinek DF, Callander NS, Roodman GD, Choi SJ.

Blood. 2004 Mar 15;103(6):2308-15.

3.

BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription.

Brocke-Heidrich K, Ge B, Cvijic H, Pfeifer G, Löffler D, Henze C, McKeithan TW, Horn F.

Oncogene. 2006 Nov 23;25(55):7297-304.

PMID:
16732314
4.

Expression profile of telomere-associated genes in multiple myeloma.

Díaz de la Guardia R, Catalina P, Panero J, Elosua C, Pulgarin A, López MB, Ayllón V, Ligero G, Slavutsky I, Leone PE.

J Cell Mol Med. 2012 Dec;16(12):3009-21. doi: 10.1111/j.1582-4934.2012.01628.x.

5.

C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance.

Rasmussen T, Knudsen LM, Dahl IM, Johnsen HE.

Leuk Lymphoma. 2003 Oct;44(10):1761-6.

PMID:
14692531
7.

TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma.

Said JW, Hoyer KK, French SW, Rosenfelt L, Garcia-Lloret M, Koh PJ, Cheng TC, Sulur GG, Pinkus GS, Kuehl WM, Rawlings DJ, Wall R, Teitell MA.

Lab Invest. 2001 Apr;81(4):555-64.

PMID:
11304575
8.

Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.

Shiao RT, McLeskey SB, Khera SY, Wolfson A, Freter CE.

Leuk Lymphoma. 1996 Apr;21(3-4):293-303.

PMID:
8726410
9.

Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication.

Misiewicz-Krzeminska I, Sarasquete ME, Quwaider D, Krzeminski P, Ticona FV, Paíno T, Delgado M, Aires A, Ocio EM, García-Sanz R, San Miguel JF, Gutiérrez NC.

Haematologica. 2013 Apr;98(4):640-8. doi: 10.3324/haematol.2012.070011.

10.
11.

Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma.

Zhu L, Somlo G, Zhou B, Shao J, Bedell V, Slovak ML, Liu X, Luo J, Yen Y.

Mol Cancer Ther. 2005 May;4(5):787-98.

12.

[Expression and clinical significance of survivin in bone marrow cells of multiple myeloma patients].

Li J, Zhao Y, Zhang DB, Huang BH.

Ai Zheng. 2005 Dec;24(12):1522-6. Chinese.

PMID:
16351806
13.

The c-ets-1 proto-oncogene is a new early-response gene differentially regulated by cytokines and growth factors in human fibroblasts.

Gilles F, Raes MB, Stéhelin D, Vandenbunder B, Fafeur V.

Exp Cell Res. 1996 Feb 1;222(2):370-8.

PMID:
8598225
14.

miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.

Chen L, Li C, Zhang R, Gao X, Qu X, Zhao M, Qiao C, Xu J, Li J.

Cancer Lett. 2011 Oct 1;309(1):62-70. doi: 10.1016/j.canlet.2011.05.017.

PMID:
21664042
15.
16.

Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.

Brocke-Heidrich K, Kretzschmar AK, Pfeifer G, Henze C, Löffler D, Koczan D, Thiesen HJ, Burger R, Gramatzki M, Horn F.

Blood. 2004 Jan 1;103(1):242-51.

17.

Cytokine network in human multiple myeloma.

Klein B, Bataille R.

Hematol Oncol Clin North Am. 1992 Apr;6(2):273-84. Review.

PMID:
1582974
18.

bax, but not bcl-2, influences the prognosis of human pancreatic cancer.

Friess H, Lu Z, Graber HU, Zimmermann A, Adler G, Korc M, Schmid RM, Büchler MW.

Gut. 1998 Sep;43(3):414-21.

19.
20.

Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation.

Giuliani N, Ferretti M, Bolzoni M, Storti P, Lazzaretti M, Dalla Palma B, Bonomini S, Martella E, Agnelli L, Neri A, Ceccarelli F, Palumbo C.

Leukemia. 2012 Jun;26(6):1391-401. doi: 10.1038/leu.2011.381.

PMID:
22289923
Items per page

Supplemental Content

Support Center